In looking back at drug price politics in March, in her April 2nd update covering the Democrats on this issue, my fellow board member Colleen Kenny LaRocque reminds us that Democrats may want bipartisanship to lower drug prices, but they don’t need it. Bipartisanship on drug prices is not dead, as Prescription Justice member Lindsay Brown informs us in “Bipartisanship is the Key to GOP's Future in Drug Prices.” Finally, I’m excited that Isaiah Cochran, MD, made his debut blog post as a Prescription Justice board member this past week.
Providing affordable medications for every single person in the United States is of the utmost importance. Many physicians and other practitioners end up having their hands tied due to the exorbitant costs of prescription medications. A first-line medication that is most efficacious for a specific disease or disorder may not be able to be utilized because a patient cannot afford the medication.
Skyrocketing prescription drug prices are a severe public health crisis affecting the daily lives of millions of Americans. The U.S. spends more on prescription drugs than any other developed country because it does not regulate drug prices.